Tranilast
Tranilast is a pharmaceutical drug with 12 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
6
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
0
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms
Efficacy and Safety of Tranilast Combined With Minocycline in the Treatment of Rosacea
Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma
Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI
A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)
Clinical Trials (12)
Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms
Efficacy and Safety of Tranilast Combined With Minocycline in the Treatment of Rosacea
Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma
Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI
A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)
A Clinical Study of Tranilast in the Treatment of Sarcoidosis
A Clinical Study of Tranilast in the Treatment of Scleredema Diabeticorum
A Clinical Study of Tranilast in the Treatment of Mucinoses
Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)
Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia
Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)
Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12